$CME

CME takes NHL team performance into futures market

CME said it will launch index-based NHL hockey futures, the first of their kind, tied to CME FutureSports Performance Indexes using real-time team statistics. Contracts are planned for Sept. 28, pending regulatory approval, with data starting in 2026-2027. CME also plans two compute futures on Oct. 5, pending review.

Original reporting
Published Aug 11, 2026, 7:54 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 8:13 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefTechnology
Primary signal
$CME
Bullish
medium confidence
Mentioned
$CME
Relevance
6/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$CMEBullishMed
01

Why it matters

If approved, the NHL futures launch provides a new hedging and speculation venue tied to sports performance indexes; compute futures could attract AI infrastructure cost hedging demand.

02

Market read

Traders can monitor regulatory approval risk and early liquidity signals ahead of the Sept. 28 and Oct. 5 launch dates.

03

What to watch

Adoption depends on index methodology acceptance, market-maker participation, and whether hedgers (sponsors/broadcasters) actually use the contracts.

Relevance 6/10Novelty 6/10Timing: Sept. 28 planned launch date, pending regulatory review.

Background

CME is extending its futures lineup with index-based contracts tied to real-time NHL team performance, and separately plans compute futures for AI infrastructure costs.

Company-level read

Ticker impact

$CMEBullishMedium confidence
Context

CME said it will launch index-based NHL hockey futures on Sept. 28, pending regulatory review, using real-time team performance stats.

Expected impact

Low to modest positive bias around the launch window; limited immediate repricing unless regulators or market adoption surprises.

Evidence & confidence

The article discloses a specific product timeline (Sept. 28) and a second compute-futures launch date (Oct. 5), both pending regulatory review, which is actionable but not yet a realized revenue event.

Market effects

Highlights continued exchange innovation in alternative and sports-linked derivatives, plus compute/AI-related futures.

Primarily US-listed derivatives market impact via CME’s product roadmap.

Could influence global derivatives product design if the NHL index-based concept gains traction internationally.

Counterpoint

Regulatory review and liquidity build-out could delay or limit adoption, making the economic impact smaller than the headline implies.

Key entities

  • CME Group

    Announced index-based NHL hockey futures launching Sept. 28 and compute futures launching Oct. 5, both pending regulatory review.

  • CME FutureSports Performance Indexes

    The performance indexes the new hockey futures will track using real-time NHL statistics.

  • National Hockey League (NHL)

    The league whose team performance statistics will feed the futures indexes.

Related articles

$TEAMMed

Stock Market Today: Dow Jones Futures Slip, S&P 500 Gains Ahead of July Jobs Report—Atlassian, Trade Desk

U.S. stock futures were mixed ahead of the July jobs report, with FactSet forecasting nonfarm payrolls up 97,500 and unemployment at 4.2%. 10-year Treasuries yielded 4.67% and FedWatch priced a 54.7% chance of a September hike. Atlassian (TEAM) rose on strong Q4 results; Trade Desk (TTD) fell on weak Q2 and soft guidance; Cloudflare (NET), Doximity (DOCS), and Sezzle (SEZL) also moved after earnings.

$NDAQMed

SEC sets Aug. 24 deadline in Nasdaq Bitcoin options review

The SEC ordered a full Commission review of Nasdaq PHLX’s proposed cash-settled Bitcoin index options (QBTC), after CME Group petitioned against a May 22 staff approval. The SEC set Aug. 24 as the deadline for written comments. The May approval remains stayed pending the Commission’s next order, with CFTC and OCC relief still required.

$CMEMed

CME Challenges Nasdaq Bitcoin Options Approval, Claims CFTC Has Exclusive Jurisdiction — BigGo Finance

CME Group challenged the SEC’s conditional approval of Nasdaq PHLX’s cash-settled bitcoin index options (ticker QBTC). CME says bitcoin is a commodity, so CFTC has exclusive jurisdiction, and the SEC exceeded its authority. The SEC initiated review and kept a stay. Comments are due Aug. 24. QBTC uses CME CF Bitcoin Real-Time Index and is cash-settled in USD.

$CMEMed

CME Says Bitcoin Index Options Fall Under CFTC, Challenges SEC Approval

CME Group challenged the SEC’s approval of Nasdaq PHLX cash-settled Bitcoin index options, arguing the product falls under CFTC jurisdiction because Bitcoin is a commodity, not a security. The SEC accepted CME’s petition July 29, stayed approval, and seeks comments through Aug. 24. Nasdaq plans to list under ticker QBTC, pending CFTC exemptive relief.